MedTrace Logo

Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

NCT02714231 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-07-19

No results posted yet for this study

Summary

The aim of our study is to compare the analgesic effect of oral diclofenac sodium versus oral hyoscine butyl bromide during intrauterine device insertion.

Conditions

  • Family Planning

Interventions

DRUG

diclofenac sodium (cataflam)

The patients in the study group will take one tablet of cataflam 50 mg 30 min before the scheduled time of the procedure

DRUG

hyoscine butyl bromide (buscopan)

The patients in the study group will take one tablet of buscopan 10 mg 30 min before the scheduled time of the procedure

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • ahmed abbas, MD · Woman health hospital Assiut

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2017-02-28
Completion
2017-03-31

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02714231 on ClinicalTrials.gov